Galera Therapeutics Funding: $11M Raised, Series A (2012)
Galera Therapeutics is based in Malvern. It has raised $11M in total funding. Latest round: Series A.
Galera Therapeutics funding overview
Galera Therapeutics is based in Malvern. Galera Therapeutics has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2012. The round record for Galera Therapeutics runs through 2012; nothing later has been disclosed. Investors on record include New Enterprise Associates (NEA), Novartis Venture Fund (NVF), Correlation Ventures. 3 distinct backers are named across the disclosed rounds.
Galera Therapeutics at a glance
Total raised
$11M
Latest round
Series A
Latest round date
December 2012
Headquarters
Malvern
Notable investors
New Enterprise Associates (NEA), Novartis Venture Fund (NVF), Correlation Ventures
Frequently asked about Galera Therapeutics funding
How much has Galera Therapeutics raised?
Galera Therapeutics has raised $11M in total disclosed funding across the rounds on record.
Who has invested in Galera Therapeutics?
New Enterprise Associates (NEA), Novartis Venture Fund (NVF), Correlation Ventures are named among the investors backing Galera Therapeutics.
What was the latest Galera Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2012.
Where is Galera Therapeutics based?
Galera Therapeutics is based in Malvern.
When did Galera Therapeutics last raise?
The last disclosed Galera Therapeutics round closed in December 2012 at Series A.
Every Galera Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Malvern at a similar stage.
